RxDoctor Payments Data

Richard Malmsten, PA

Physician Assistant · Holland, MINPI 1588752562

Payments from drug & device makers

$672in general payments, 2019–2025

Across 34 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$185
  • Boehringer Ingelheim$117
  • GSK$92
  • Mylan Specialty L.p.$82
  • Mallinckrodt Hospital Products Inc.$35
  • Insmed, Inc.$33
  • plus $128 from 5 others

What the payments were for

  • Food & beverage$672100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$672 in reported general payments places this provider in the 65th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$6,931
Medicare patients
68
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter369$386,491
Fluticasone-SalmeterolFluticasone Propion/Salmeterol278$70,672
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr70$63,141
NucalaMepolizumab11$39,565
Spiriva RespimatTiotropium Bromide56$38,234
Breztri AerosphereBudesonide/Glycopyr/Formoterol33$33,016
Breo ElliptaFluticasone/Vilanterol37$23,700
Qvar RedihalerBeclomethasone Dipropionate58$20,782
Spiriva HandihalerTiotropium Bromide27$20,548
SymbicortBudesonide/Formoterol Fumarate40$15,847
Albuterol Sulfate HfaAlbuterol Sulfate396$15,537
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$15,086
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate39$14,712
Advair HfaFluticasone Propion/Salmeterol20$14,677
Pulmicort FlexhalerBudesonide27$12,404

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Nucala, Breo Ellipta, Arnuity Ellipta$92$530,865521 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat$117$64,38584 claims
AstraZenecaBreztri Aerosphere, Symbicort, Pulmicort Flexhaler$185$61,267100 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Holland

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →